Clinical and biochemical parameters | NC-AME | Controls |
---|---|---|
n | 10 | 15 |
Female, % | 60% (6/10) | 53.3% (8/15) |
Age, years | 24.4 [12.3–42.7] | 25.8 [12.1–47.13] |
BMI, kg/m2 | 27.3 [22.0–28.9] | 24.6 [21.0–28.9] |
SBP, mmHg | 126.5 [110.3–154.1] | 124.3 [108.0–143.3] |
DBP, mmHg | 73.8 [66.6–84.4] | 78.0 [68.3–85.0] |
Aldosterone, ng/dl | 8.9 [4.7–13.5] | 12.7 [7.4–15.6] |
PRA, ng/ml*h | 1.2 [0.7–2.2] | 2.1 [1.5–3.5] |
Serum K+, mEq/l | 4.0 [3.8–4.4] | 4.5 [4.1–4.8]* |
Serum Cortisol, µg/dl | 12.5 [9.4–13.8] | 8.1 [7.8–12.1] |
Serum Cortisone, µg/dl | 1.9 [1.8–2.1] | 3.0 [2.5–3.1]* |
Serum F/E ratio | 6.0 [4.6–6.7] | 3.1 [2.3–4.2]* |
FEK 24 h % | 7.9 [6.0–9.0] | 5.9 [4.7–7.2]* |
Urinary sodium excretion, mEq/24 h | 138.5 [54.5–215.8] | 128.0 [71.0–199.0] |
Urinary potassium excretion, mEq/24 h | 49.0 [35.8–72.3] | 53.0 [35.0–60.0] |
Urinary Na+/K+ ratio | 2.1 [1.4–3.7] | 2.6 [1.9–3.8] |
TTKG | 5.6 [4.4–7.2] | 4.4 [3.5–4.9] |
Urinary F/E ratio | 0.5 [0.4–0.5] | 0.3 [0.3–0.4]* |
(THF + allo-THF)/THE ratio | 0.7 [0.6–0.8] | 0.6 [0.5–0.9] |